Autres langues Scholar Rock Holding Corporation

Actions

SRRK

US80706P1030

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 02/05/2024			Varia. 5j.	Varia. 1 janv.
15,1 ^USD	+0,94%		+8,17%	-19,68%

28/03	Les actions de Scholar Rock augmentent après que Raymond James ait initié une couverture	MT
28/03	SCHOLAR ROCK HOLDING CORPORATION : Raymond James revoit son opinion à la hausse	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Scholar Rock Reports New Employee Inducement Grants under Nasdaq Listing Rule 5635(4)	15/04
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	12/04
Scholar Rock Shares Rise After Raymond James Initiates Coverage	28/03
Scholar Rock Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress	19/03
Scholar Rock Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
North American Morning Briefing : Investors -2-	18/03
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	15/03
North American Morning Briefing : Stock Futures -2-	11/03
Scholar Rock : Corporate Presentation March 2024	05/03
Scholar Rock to Participate in Upcoming Investor Conferences	28/02
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	16/02
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer	15/02
Scholar Rock Announces Management Appointments	15/02
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management	06/02
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management	06/02
Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia	25/01
Scholar Rock Says FDA Clears Application for Trial of Obesity Treatment Apitegromab	23/01
Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity	23/01
Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity	23/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Scholar Rock Holding Corporation

Actions

SRRK

US80706P1030

Autres langues

Filtres